Australia markets close in 3 hours 44 minutes
  • ALL ORDS

    7,770.00
    +43.20 (+0.56%)
     
  • ASX 200

    7,461.90
    +46.40 (+0.63%)
     
  • AUD/USD

    0.7477
    +0.0009 (+0.12%)
     
  • OIL

    84.37
    +0.61 (+0.73%)
     
  • GOLD

    1,795.60
    -0.70 (-0.04%)
     
  • BTC-AUD

    82,709.03
    +560.23 (+0.68%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • AUD/EUR

    0.6420
    +0.0013 (+0.20%)
     
  • AUD/NZD

    1.0444
    +0.0016 (+0.15%)
     
  • NZX 50

    13,093.24
    -32.76 (-0.25%)
     
  • NASDAQ

    15,355.07
    -134.53 (-0.87%)
     
  • FTSE

    7,204.55
    +14.25 (+0.20%)
     
  • Dow Jones

    35,677.02
    +73.92 (+0.21%)
     
  • DAX

    15,542.98
    +70.38 (+0.45%)
     
  • Hang Seng

    26,126.93
    +109.43 (+0.42%)
     
  • NIKKEI 225

    28,631.89
    -172.96 (-0.60%)
     

3 reasons why FDA advisors rejected Pfizer’s booster for the general public

In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Meg Fitzgerald, “Ascending Davos” Author and Columbia University Healthcare Policy Professor, joins Yahoo Finance Live to discuss the future of vaccines, the FDA rejecting Pfizer's booster shot for the general public and the importance of getting young children vaccinated as soon as possible.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting